MPZL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.054400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.170800E-01
Normal-vs-Stage2
2.781400E-01
Normal-vs-Stage3
8.617400E-01
Normal-vs-Stage4
1.051760E-01
Stage1-vs-Stage2
4.911200E-01
Stage1-vs-Stage3
3.154600E-01
Stage1-vs-Stage4
5.728600E-01
Stage2-vs-Stage3
2.822800E-01
Stage2-vs-Stage4
1.182440E-01
Stage3-vs-Stage4
1.044560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.089200E-01
Normal-vs-AfricanAmerican
2.505800E-01
Normal-vs-Asian
5.443600E-01
Caucasian-vs-AfricanAmerican
3.109800E-01
Caucasian-vs-Asian
5.610200E-01
AfricanAmerican-vs-Asian
1.541180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.219000E-01
Normal-vs-Female
2.821600E-01
Male-vs-Female
4.850200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.927800E-01
Normal-vs-Age(41-60Yrs)
2.076000E-01
Normal-vs-Age(61-80Yrs)
3.417400E-01
Normal-vs-Age(81-100Yrs)
5.170000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.143000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.780200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.172000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.478040E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.002400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.058200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.729400E-01
Normal-vs-Daily Drinker
5.363800E-01
Normal-vs-Weekly Drinker
6.590600E-01
Normal-vs-Occasional Drinker
1.518630E-01
Normal-vs-Social Drinker
3.379800E-01
Non Drinker-vs-Daily Drinker
3.427000E-01
Non Drinker-vs-Weekly Drinker
1.238390E-01
Non Drinker-vs-Occasional Drinker
9.589800E-02
Non Drinker-vs-Social Drinker
2.065000E-01
Daily Drinker-vs-Weekly Drinker
5.424800E-01
Daily Drinker-vs-Occasional Drinker
3.003900E-02
Daily Drinker-vs-Social Drinker
9.053000E-01
Weekly Drinker-vs-Occasional Drinker
1.002480E-02
Weekly Drinker-vs-Social Drinker
5.033400E-01
Occasional Drinker-vs-Social Drinker
2.137500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.513400E-01
Normal-vs-Grade 2
6.658000E-02
Normal-vs-Grade 3
1.653980E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.024400E-01
Grade 1-vs-Grade 3
1.123150E-01
Grade 1-vs-Grade 4
2.513400E-01
Grade 2-vs-Grade 3
4.539400E-01
Grade 2-vs-Grade 4
6.658000E-02
Grade 3-vs-Grade 4
1.653980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.917000E-01
Normal-vs-NonDiabetic
3.250400E-01
Diabetic-vs-NonDiabetic
5.636200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.068370E-01
Normal-vs-NoPancreatitis
3.513000E-01
Pancreatitis-vs-NoPancreatitis
2.460400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.011800E-01
Normal-vs-N1
2.924400E-01
N0-vs-N1
8.340000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.604570E-03
Normal-vs-TP53-NonMutant
3.646400E-01
TP53-Mutant-vs-TP53-NonMutant
6.838100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
